AU2001238653A1 - Method for treating hashimoto's thyroiditis - Google Patents

Method for treating hashimoto's thyroiditis

Info

Publication number
AU2001238653A1
AU2001238653A1 AU2001238653A AU3865301A AU2001238653A1 AU 2001238653 A1 AU2001238653 A1 AU 2001238653A1 AU 2001238653 A AU2001238653 A AU 2001238653A AU 3865301 A AU3865301 A AU 3865301A AU 2001238653 A1 AU2001238653 A1 AU 2001238653A1
Authority
AU
Australia
Prior art keywords
thyroiditis
treating hashimoto
hashimoto
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001238653A
Inventor
Stephen Donovan
Martin A. Voet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Sales LLC
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Publication of AU2001238653A1 publication Critical patent/AU2001238653A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001238653A 2000-02-24 2001-02-23 Method for treating hashimoto's thyroiditis Abandoned AU2001238653A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/512,110 US6358513B1 (en) 2000-02-15 2000-02-24 Method for treating Hashimoto's thyroiditis
US09512110 2000-02-24
PCT/US2001/005773 WO2001062270A2 (en) 2000-02-24 2001-02-23 Method for treating hashimoto's thyroiditis

Publications (1)

Publication Number Publication Date
AU2001238653A1 true AU2001238653A1 (en) 2001-09-03

Family

ID=24037709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001238653A Abandoned AU2001238653A1 (en) 2000-02-24 2001-02-23 Method for treating hashimoto's thyroiditis

Country Status (3)

Country Link
US (1) US6358513B1 (en)
AU (1) AU2001238653A1 (en)
WO (1) WO2001062270A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW574036B (en) 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin
US6821520B2 (en) * 2000-02-15 2004-11-23 Allergan, Inc. Clostridial toxin therapy for Hashimoto's thyroiditis
US6773711B2 (en) * 2000-02-15 2004-08-10 Allergan, Inc. Botulinum toxin therapy for Hashimoto's thyroiditis
US6524580B1 (en) * 2000-02-15 2003-02-25 Allergan Sales, Inc. Method for treating thyroid disorders
US20040170665A1 (en) * 2000-06-02 2004-09-02 Allergan, Inc. Intravitreal botulinum toxin implant
US20040033241A1 (en) * 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
US7491799B2 (en) * 2000-07-21 2009-02-17 Allergan, Inc. Modified botulinum neurotoxins
US7691983B2 (en) * 2000-07-21 2010-04-06 Allergan, Inc. Chimera botulinum toxin type E
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
JP4707254B2 (en) * 2001-04-24 2011-06-22 クミアイ化学工業株式会社 Granular composition and method for producing the same
US20030224019A1 (en) * 2002-03-01 2003-12-04 O'brien Christopher Methods of treating nerve entrapment syndromes
US7238357B2 (en) * 2002-11-05 2007-07-03 Allergan, Inc. Methods for treating ulcers and gastroesophageal reflux disease
US20040086532A1 (en) * 2002-11-05 2004-05-06 Allergan, Inc., Botulinum toxin formulations for oral administration
JP2007528352A (en) * 2003-03-06 2007-10-11 ボツリヌム・トクシン・リサーチ・アソシエイツ・インコーポレイテッド Treatment of chronic facial pain and headache associated with sinusitis with botulinum toxin
US7390496B2 (en) * 2003-04-25 2008-06-24 Allergan, Inc. Therapeutic treatments for repetitive hand washing
US7396535B2 (en) * 2003-04-25 2008-07-08 Ackerman Alan H Therapy for obsessive compulsive head banging
US7393537B2 (en) * 2003-04-25 2008-07-01 Allergan, Inc. Botulinum toxin for treatment of obsessive compulsive finger biting disorder
US7422753B2 (en) * 2003-04-25 2008-09-09 Allergan, Inc. Methods for treating trichotillomania
US7393538B2 (en) * 2003-04-25 2008-07-01 Ackerman Alan H Clostridial toxin treatment for dermatillomania
US6838434B2 (en) * 2003-05-02 2005-01-04 Allergan, Inc. Methods for treating sinus headache
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US20040253274A1 (en) * 2003-06-11 2004-12-16 Allergan, Inc. Use of a clostridial toxin to reduce appetite
US20050013850A1 (en) * 2003-07-15 2005-01-20 Caers Jan K. Device to assist hyperhydrosis therapy
US8617572B2 (en) 2003-10-29 2013-12-31 Allergan, Inc. Botulinum toxin treatments of depression
US8609112B2 (en) 2003-10-29 2013-12-17 Allergan, Inc. Botulinum toxin treatments of depression
US8734810B2 (en) 2003-10-29 2014-05-27 Allergan, Inc. Botulinum toxin treatments of neurological and neuropsychiatric disorders
US8609113B2 (en) 2003-10-29 2013-12-17 Allergan, Inc. Botulinum toxin treatments of depression
US7172764B2 (en) * 2003-11-17 2007-02-06 Allergan, Inc. Rescue agents for treating botulinum toxin intoxications
US20050129677A1 (en) * 2003-12-10 2005-06-16 Shengwen Li Lipid rafts and clostridial toxins
US20050148935A1 (en) * 2003-12-29 2005-07-07 Rozalina Dimitrova Botulinum toxin injection guide
WO2006130161A2 (en) * 2004-07-21 2006-12-07 The Cornell Research Foundation, Inc. Therapeutic compounds derived from spider venom and their method of use
US20060024794A1 (en) * 2004-07-30 2006-02-02 Shengwen Li Novel methods for production of di-chain botulinum toxin
US7910116B2 (en) * 2005-08-24 2011-03-22 Allergan, Inc. Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
US7794386B2 (en) 2006-03-15 2010-09-14 Allergan, Inc. Methods for facilitating weight loss
US7811586B2 (en) * 2006-05-02 2010-10-12 Allergan, Inc. Methods for alleviating testicular pain
US20080092910A1 (en) * 2006-10-18 2008-04-24 Allergan, Inc. Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures
US20080113051A1 (en) * 2006-11-13 2008-05-15 Allergan, Inc. Methods for alleviating tattoo pain
US8470337B2 (en) * 2008-03-13 2013-06-25 Allergan, Inc. Therapeutic treatments using botulinum neurotoxin
US20120220875A1 (en) * 2010-04-20 2012-08-30 Suri Jasjit S Mobile Architecture Using Cloud for Hashimoto's Thyroiditis Disease Classification
US20130030281A1 (en) * 2010-04-20 2013-01-31 Jasjit S Suri Hashimotos Thyroiditis Detection and Monitoring
US8992941B2 (en) 2011-07-08 2015-03-31 Allergan, Inc. Method for treatment of esophageal spasm
AU2012282873B2 (en) 2011-07-08 2016-03-31 Allergan, Inc. Method for treatment of autonomic nervous system disorders
CN103813802A (en) 2011-07-14 2014-05-21 阿勒根公司 Methods for treatment of incontinence associated with sexual activity
CN103702681A (en) 2011-07-20 2014-04-02 阿勒根公司 Botulinum toxins for use in a method for treatment of adipose deposits
US20140163327A1 (en) * 2012-12-12 2014-06-12 Boston Scientific Scimed, Inc Method and system for remote thyroidectomy and parathyroidectomy
US10149893B2 (en) 2013-09-24 2018-12-11 Allergan, Inc. Methods for modifying progression of osteoarthritis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE156361T1 (en) 1992-09-21 1997-08-15 Upjohn Co PROTEIN-CONTAINED MEDICINAL PRODUCTS WITH DELAYED RELEASE
CA2150803C (en) 1992-12-02 2006-01-31 Henry Auer Controlled release growth hormone containing microspheres
DE69435254D1 (en) * 1993-06-10 2009-12-31 Allergan Inc Treatment of neuromuscular disorders and conditions with various botulism serotypes
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
EP0737074B1 (en) * 1993-12-28 2001-08-01 Allergan Sales, Inc. Botulinum toxins for treating hyperhydrosis
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US6063405A (en) 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
US5980945A (en) 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
PT1011695E (en) 1997-07-15 2006-07-31 Univ Colorado USING NEUROTOXIN THERAPY FOR TREATMENT OF PROSTATE DISEASES
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6022554A (en) 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
GB9818548D0 (en) 1998-08-25 1998-10-21 Microbiological Res Authority Treatment of mucas hypersecretion

Also Published As

Publication number Publication date
US6358513B1 (en) 2002-03-19
WO2001062270A3 (en) 2002-02-21
WO2001062270A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
AU2001238653A1 (en) Method for treating hashimoto's thyroiditis
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU1833699A (en) Device and method for treating parkinson's disease
AU2593900A (en) Composition and method for treating glaucoma
AU9035498A (en) Method for treating pain
SG76650A1 (en) Photoresist stripping composition and process for stripping photoresist
AU2002219945A1 (en) Composition and method for treating snoring
AU7823098A (en) Methods for treating obesity
AUPP794698A0 (en) Waste treatment apparatus
AU2695300A (en) Waste treating method
IL135584A0 (en) Method for treating alzheimer's disease
AU2002246490A1 (en) Method of treating parkinson's disease
IL141648A0 (en) A method for the treatment of staphylococcal disease
HUP0101779A3 (en) Process for de-chlorinating and de-fouling waste-oil
AU5733099A (en) Method for treating ocular neovascular diseases
HUP9902097A3 (en) Method for treating glaucoma
AU4672597A (en) Method for treating urinary reflux
AU2571099A (en) Novel water treatment device and method
AU9034798A (en) Method for treating pain
AU6360999A (en) Process for producing 4-arylpiperidine-3-carbinols and related compounds
AU6215798A (en) Process for the treatment of waste waters
AU2002242348A1 (en) Process for obtaining 3'-epilutein
AUPQ922100A0 (en) Waste treatment process
AU3400797A (en) A method for treating meniere's disease
GB9814785D0 (en) Waste treatment method